Literature DB >> 12134956

Preparation and characterization of mono-PEGylated epidermal growth factor: evaluation of in vitro biologic activity.

Haeshin Lee1, Tae Gwan Park.   

Abstract

PURPOSE: To isolate mono-PEGylated epidermal growth factor (EGF) isoforms, identify the site of PEGylation, and evaluate the biologic activity of each isoform.
METHODS: EGF was PEGylated with an NHS-PEG derivative (Mw 3,400). Mono-PEGylated EGF fraction was separated by gel-filtration HPLC and three mono-PEGylated EGF isoforms were purified by RP-HPLC. Tryptic digestion mapping of both EGF and mono-PEGylated EGF isoforms was performed to identify the PEGylation sites using RP-HPLC. The digested fragments were also analyzed by matrix-assisted laser desorption and ionization time of flight (MALDI-TOF) mass spectroscopy for further verification of the three PEG conjugation sites. The biologic activity of positional isoforms was evaluated by a cell proliferation assay and a receptor tyrosine kinase activity assay to determine the effect of PEGylation site on its activity.
RESULTS: Mono-PEGylated EGF was composed of three positional isomers. Tryptic digestion mapping and MALDI-TOF analysis permitted the identification of the PEGylated site of the three isoforms at N-terminus. Lysine 28, and Lysine 48. PEG-N-terminus EGF, among the three positional isomers, showed the highest activity in a cell proliferation assay and in a receptor-binding assay.
CONCLUSION: This study demonstrates that biologic activities of mono-PEGylated EGF isomers are highly dependent upon the site of PEGylation in EGF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134956     DOI: 10.1023/a:1016113117851

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Synthesis and characterization of poly(ethylene glycol)-insulin conjugates.

Authors:  K Hinds; J J Koh; L Joss; F Liu; M Baudys; S W Kim
Journal:  Bioconjug Chem       Date:  2000 Mar-Apr       Impact factor: 4.774

2.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal.

Authors:  S COHEN
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

3.  Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity.

Authors:  S P Monkarsh; Y Ma; A Aglione; P Bailon; D Ciolek; B DeBarbieri; M C Graves; K Hollfelder; H Michel; A Palleroni; J E Porter; E Russoman; S Roy; Y C Pan
Journal:  Anal Biochem       Date:  1997-05-01       Impact factor: 3.365

4.  Evidence that autophosphorylation of solubilized receptors for epidermal growth factor is mediated by intermolecular cross-phosphorylation.

Authors:  A M Honegger; R M Kris; A Ullrich; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  The solution structure of human epidermal growth factor.

Authors:  R M Cooke; A J Wilkinson; M Baron; A Pastore; M J Tappin; I D Campbell; H Gregory; B Sheard
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

6.  Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase.

Authors:  P R Kuhl; L G Griffith-Cima
Journal:  Nat Med       Date:  1996-09       Impact factor: 53.440

7.  Substitution of lysine for arginine at position 42 of human transforming growth factor-alpha eliminates biological activity without changing internal disulfide bonds.

Authors:  D Defeo-Jones; J Y Tai; G A Vuocolo; R J Wegrzyn; T L Schofield; M W Riemen; A Oliff
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

8.  Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes.

Authors:  D J Mooney; P M Kaufmann; K Sano; S P Schwendeman; K Majahod; B Schloo; J P Vacanti; R Langer
Journal:  Biotechnol Bioeng       Date:  1996-05-20       Impact factor: 4.530

9.  Conformational characterization of a single-site mutant of murine epidermal growth factor (EGF) by 1H NMR provides evidence that leucine-47 is involved in the interactions with the EGF receptor.

Authors:  F J Moy; H A Scheraga; J F Liu; R Wu; G T Montelione
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture.

Authors:  D W Barnes
Journal:  J Cell Biol       Date:  1982-04       Impact factor: 10.539

View more
  6 in total

Review 1.  PEGylation of interferon-β-1a: a promising strategy in multiple sclerosis.

Authors:  Bernd C Kieseier; Peter A Calabresi
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

Review 2.  Approaches for enhancing oral bioavailability of peptides and proteins.

Authors:  Jwala Renukuntla; Aswani Dutt Vadlapudi; Ashaben Patel; Sai H S Boddu; Ashim K Mitra
Journal:  Int J Pharm       Date:  2013-02-18       Impact factor: 5.875

3.  PEGylation of brain-derived neurotrophic factor for preserved biological activity and enhanced spinal cord distribution.

Authors:  Ryan G Soderquist; Erin D Milligan; Evan M Sloane; Jacqueline A Harrison; Klarika K Douvas; Joseph M Potter; Travis S Hughes; Raymond A Chavez; Kirk Johnson; Linda R Watkins; Melissa J Mahoney
Journal:  J Biomed Mater Res A       Date:  2009-12       Impact factor: 4.396

4.  PEGylation of interleukin-10 for the mitigation of enhanced pain states.

Authors:  Ryan G Soderquist; Erin D Milligan; Jacqueline A Harrison; Raymond A Chavez; Kirk W Johnson; Linda R Watkins; Melissa J Mahoney
Journal:  J Biomed Mater Res A       Date:  2010-06-01       Impact factor: 4.396

5.  N-terminal site-specific mono-PEGylation of epidermal growth factor.

Authors:  Haeshin Lee; Il Ho Jang; Sung Ho Ryu; Tae Gwan Park
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

6.  Controlled Release of Epidermal Growth Factor from Furfuryl-Gelatin Hydrogel Using in Situ Visible Light-Induced Crosslinking and Its Effects on Fibroblasts Proliferation and Migration.

Authors:  Min Sun Kong; Won-Gun Koh; Hyun Jong Lee
Journal:  Gels       Date:  2022-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.